Nature Medicine

• 

  Publication Venue For

  • Communicating health information with visual displays..  29:1085-1091. 2023
  • Publisher Correction: Pepinemab antibody blockade of SEMA4D in early Huntington’s disease: a randomized, placebo-controlled, phase 2 trial (Nature Medicine, (2022), 10.1038/s41591-022-01919-8) 2022
  • Distinct mechanisms of long-term virologic control in two HIV-infected individuals after treatment interruption of anti-retroviral therapy..  27:1893-1898. 2021
  • How kindness can be contagious in healthcare..  27:1142-1144. 2021
  • Wearable sensors enable personalized predictions of clinical laboratory measurements..  27:1105-1112. 2021
  • Digital technology and COVID-19..  26:459-461. 2020
  • Implications of legacy lead for children's brain development..  26:23-25. 2020
  • A longitudinal big data approach for precision health..  25:792-804. 2019
  • Gene therapies for hemophilia hit the mark in clinical trials..  24:121-122. 2018
  • Retinal lipid and glucose metabolism dictates angiogenesis through the lipid sensor Ffar1.  22:439-445. 2016
  • Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition..  20:732-740. 2014
  • CRISPR technology for gene therapy..  20:476-477. 2014
  • Cross-talk between hypoxia and insulin signaling through Phd3 regulates hepatic glucose and lipid metabolism and ameliorates diabetes.  19:1325-1330. 2013
  • LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker.  18:1511-1517. 2012
  • Simultaneous functional photoacoustic and ultrasonic endoscopy of internal organs in vivo..  18:1297-1302. 2012
  • Erratum: Modulating hedgehog signaling can attenuate the severity of osteoarthritis (Nature Medicine (2009) 15 (1421-1425)).  16:129. 2010
  • Erratum: The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases (Nature Medicine (2009) 15 (177-184)).  15:462. 2009
  • The commercialism of academic research.  14:1014-1014. 2008
  • Corrigenda: Genomic signatures to guide the use of chemotherapeutics..  13:1388. 2007
  • Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia..  13:1203-1210. 2007
  • Cyclic AMP-regulated exocytosis of Escherichia coli from infected bladder epithelial cells..  13:625-630. 2007
  • The bridge between dendritic cells and asthma..  13:536-538. 2007
  • Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants..  13:100-106. 2007
  • Gut microbes out of control in HIV infection..  12:1351-1352. 2006
  • GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence..  12:1269-1277. 2006
  • Erratum: Epidemiologic and economic consequences of the global epidemics of obesity and diabetes (Nature Medicine (2006) 12, (62-66)).  12:367. 2006
  • Epidemiologic and economic consequences of the global epidemics of obesity and diabetes..  12:62-66. 2006
  • Trans-arachidonic acids generated during nitrative stress induce a thrombospondin-1-dependent microvascular degeneration..  11:1339-1345. 2005
  • Amelioration of inflammatory arthritis by targeting the pre-ligand assembly domain of tumor necrosis factor receptors..  11:1066-1072. 2005
  • A crucial role for GRK2 in regulation of endothelial cell nitric oxide synthase function in portal hypertension..  11:952-958. 2005
  • Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells..  11:367-368. 2005
  • Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy..  11:214-222. 2005
  • Re-engineered CD40 receptor enables potent pharmacological activation of dendritic-cell cancer vaccines in vivo..  11:130-137. 2005
  • Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry..  11:85-89. 2005
  • Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis..  10:1216-1221. 2004
  • Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival..  10:942-949. 2004
  • Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of Vegf-A..  10:950-958. 2004
  • PET concerns in bevacizumab treatment..  10:561. 2004
  • Fat hormones pull their weight in the CNS..  10:454-455. 2004
  • Noninvasive cineangiography by magnetic resonance global coherent free precession..  10:545-549. 2004
  • Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance..  10:268-274. 2004
  • Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer..  10:145-147. 2004
  • Erratum: Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer (Nature Medicine (2004) 10 (145-147)).  10:649. 2004
  • Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts..  9:1195-1201. 2003
  • Pigment epithelium-derived factor regulates the vasculature and mass of the prostate and pancreas..  9:774-780. 2003
  • C75 inhibits food intake by increasing CNS glucose metabolism..  9:483-485. 2003
  • Sensing heart stress..  9:19-20. 2003
  • Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies..  8:1249-1256. 2002
  • A futile metabolic cycle activated in adipocytes by antidiabetic agents..  8:1122-1128. 2002
  • Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery..  8:864-871. 2002
  • Nitric oxide in the human respiratory cycle..  8:711-717. 2002
  • Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy..  8:522-526. 2002
  • The other physician-scientist problem: where have all the young girls gone?.  8:439-441. 2002
  • Cloned mice have an obese phenotype not transmitted to their offspring..  8:262-267. 2002
  • Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy..  8:253-261. 2002
  • Metabolism of PGE2 by prostaglandin dehydrogenase is essential for remodeling the ductus arteriosus..  8:91-92. 2002
  • Epilepsy and all that jazz..  7:1103-1105. 2001
  • Can the thymus win the battle against drug-resistant HIV?.  7:661-662. 2001
  • Plasma fibronectin supports neuronal survival and reduces brain injury following transient focal cerebral ischemia but is not essential for skin-wound healing and hemostasis..  7:324-330. 2001
  • LMP2 expression and proteasome activity in NOD mice..  6:1064. 2000
  • LMP2 expression and proteasome activity in NOD mice..  6:1064-1065. 2000
  • Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells..  6:1011-1017. 2000
  • Metformin reverses fatty liver disease in obese, leptin-deficient mice..  6:998-1003. 2000
  • Gene therapy for human SCID: dreams become reality..  6:623-624. 2000
  • Transgenic expression of green fluorescence protein can cause dilated cardiomyopathy..  6:482-483. 2000
  • Reply to Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand.  6:114-114. 2000
  • Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1..  6:41-48. 2000
  • Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice..  5:1199-1202. 1999
  • Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients..  5:677-685. 1999
  • Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates..  5:686-693. 1999
  • Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations..  5:526-534. 1999
  • Gene expression in space..  5:359. 1999
  • Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis..  5:347-350. 1999
  • Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry..  4:1302-1307. 1998
  • Expression of heme oxygenase-1 can determine cardiac xenograft survival..  4:1073-1077. 1998
  • Regenerating functional myocardium: improved performance after skeletal myoblast transplantation..  4:929-933. 1998
  • T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates..  4:775-780. 1998
  • Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging..  4:623-626. 1998
  • Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis..  4:615-618. 1998
  • Ejaculatory abnormalities in mice with targeted disruption of the gene for heme oxygenase-2..  4:84-87. 1998
  • Quantitative angiogenesis assays: progress and problems..  3:1203-1208. 1997
  • To oxidize or not to oxidize?.  3:1192-1193. 1997
  • The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression..  3:1160-1162. 1997
  • Immunostimulatory DNA: a clear and present danger?.  3:829-831. 1997
  • Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation..  3:177-182. 1997
  • Inhibition of cell proliferation by an RNA ligand that selectively blocks E2F function..  2:1386-1389. 1996
  • Functional imaging of the lung..  2:1192. 1996
  • A role for GAPDH in apoptosis and neurodegeneration..  2:609-610. 1996
  • Reply to “A role for GAPDH in apoptosis and neurodegeneration”.  2:610-610. 1996
  • Tagging ribozyme reaction sites to follow trans-splicing in mammalian cells..  2:643-648. 1996
  • Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection..  2:405-411. 1996
  • Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH..  2:347-350. 1996
  • Human gene therapy--of tortoises and hares..  1:1137-1138. 1995
  • Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency..  1:1017-1023. 1995
  • Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostate..  1:944-949. 1995
  • Heart and lung disease in engineered mice..  1:749-751. 1995
  • Failure of T-cell homeostasis preceding AIDS in HIV-1 infection. The Multicenter AIDS Cohort Study..  1:674-680. 1995
  • Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression..  1:330-336. 1995
  • Corrigendum: Genomic signatures to guide the use of chemotherapeutics (Nature Medicine (2006) 12, (1294-1300)).  14:889. 2008
  • Erratum: Genomic signatures to guide the use of chemotherapeutics (Nature (2006) 12, (1294-1300)).  13:1388. 2007
  • Genomic signatures to guide the use of chemotherapeutics..  12:1294-1300. 2006
  • Neutralizing antibodies take a swipe at HIV in vivo..  11:593-594. 2005
  • HIV-1: nature's master of disguise..  9:393-394. 2003
  • Location, location, location: regional immune mechanisms critically influence rejection..  8:553-555. 2002
  • Hitting the reset button for immune tolerance..  7:24-25. 2001
  • Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand..  6:114. 2000
  • Erratum: Regenerating functional myocardium: Improved performance after skeletal myoblast transplantation.  4:1200-1200. 1998